Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.
Petersen LF, Klimowicz AC, Otsuka S, Elegbede AA, Petrillo SK, Williamson T, Williamson CT, Konno M, Lees-Miller SP, Hao D, Morris D, Magliocco AM, Bebb DG.
Petersen LF, et al. Among authors: morris d.
Oncotarget. 2017 Jun 13;8(24):38326-38336. doi: 10.18632/oncotarget.16215.
Oncotarget. 2017.
PMID: 28418844
Free PMC article.